Target intelligence / Profile preview

Natural Killer T Cell (NKT)

Target
NKT
Molecular classification
Lymphocyte, Innate lymphoid cell, T cell
01

Overview

Natural killer T (NKT) cells are a unique subset of immune cells that share features of both conventional T lymphocytes and natural killer (NK) cells. They are characterized by their ability to recognize lipid antigens presented by the CD1d molecule, rather than peptide antigens presented by classical major histocompatibility complex (MHC) molecules. NKT cells play a critical role in modulating immune responses against infections, tumors, autoimmunity, and inflammation. Upon activation via their semi-invariant TCRs engaging glycolipid-CD1d complexes, NKT cells rapidly secrete large amounts of cytokines including interleukin 4 (IL-4), interferon gamma (IFNγ), and others associated with Th1/Th2 responses. They can directly kill target infected or malignant cells through cytotoxic mechanisms or indirectly modulate other immune cell functions via cytokine release. Their rapid response allows them to influence early phases of immune reactions against pathogens or tumors.

Other names
NKT cellNatural killer T-cell
02

Mechanism of action

Synthetic glycolipid agonists like alpha-galactosylceramide can be used to activate NKT cells, promoting cytokine secretion and cytotoxicity against target cells.

03

Biological functions

Immune responseCytokine secretionCytotoxicityImmune regulationAntigen presentationModulation of immune responses
04

Disease associations

InfectionTumorAutoimmunityInflammationTissue graft rejectionAllergic reactions
05

Safety considerations

Potential for cytokine storm upon excessive activationRisk of autoimmunity or immune-related adverse eventsTumor escape mechanisms related to NKT cell dysfunction or suppression
06

Interacting drugs

alpha-galactosylceramide
07

Biomarkers

NKT cell count in peripheral bloodExpression levels of NKT cell surface markers (e.g., CD1d tetramer staining)Cytokine production profile (e.g., IL-4, IFNγ)TCR Vα24Jα18 and Vβ11 expression in humans

Beyond the preview

Go deeper on Natural Killer T Cell (NKT).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Natural Killer T Cell (NKT).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call